Bayer's Werner Wenning

Werner Wenning, Bayer CEO

Werner Wenning - Bayer

Total Compensation: $4.86M

Details: Wenning's 2008 salary rounded out to €3.66 million--or $4.87 million--only a slight increase over the €3.6 million he was awarded last year. His base salary was bumped about 6 percent to $1,056,000, while his bonus was cut by 3 percent to $2.8 million. Wenning also received a $457,520 supplement, another half a million in stock and $81,000 for such perks as personal use of the company car and healthcare costs.

Bayer news:
Bayer ignored FDA; Congress asks why
Bayer on the prowl for weaker prey
Bayer CEO scoffs at takeover talk
Bayer fined $16.2M in price-fixing probe

Bayer's Werner Wenning
Read more on

Suggested Articles

The FDA wants to know what, exactly, is in a drug name—and whether it influences how the product is perceived. So it's launching a study to find out.

Horizon Therapeutics has notched an FDA approval for its rare eye disease med Tepezza (teprotumumab), a possible blockbuster drug in the making.

Eli Lilly has a pipeline stuffed with a host of assets and has decided it needs a new injectable drug and device plant to manufacture some of them.